ABSTRACT
In this, the second article in the second section of the cytochromes P450 review series on regulation of foreign compound metabolizing genes, the molecular regulation of the CYP4A gene family is addressed.
As initially reported
by Isseman and Green in 1990 (see ref 7) , many of the pleotropic changes evoked by exposure of ammals to peroxisome proliferators are due to the action of a unique member of the nuclear hormone family, which includes receptors for thyroid hormone, retinoic acid, 9-cis retinoic acid, and vitamin D3. This receptor is the peroxisome proliferator-activated receptor (PPAR). In this review, Johnson and co-workers describe the minimal sequence requirements for regulation of the rabbit CYP4A6 gene by peroxisome proliferators.
The requirement for multiple copies of consensus-responsive elements (AGGTCA) separated by a single nucleotide provides unique regulation of these genes due to the ability of other nuclear transcription factors (both ligand-activated and unliganded)
to bind with PPAR as heterodimers. Similarities in the regulation of the CYP4A genes and other genes regulated by PPAR are discussed. PEROXISOME PROLIFERATORS are a structurally diverse group of compounds that cause the number and size of peroxisomes to increase in some animal species (1, 2) . Chronic exposure leads to the development of liver byperplasia, hepatomeglia, and tumors in these animals. These effects are preceded by the induction of a number of peroxisomal enzymes that metabolize fatty acids, as well as the increased expression of related enzymes and binding proteins in other cellular compartments.
The microsomal cytochrome P450 4A' enzymes are among the proteins that are induced by peroxisome proliferators (3) , and this effect reflects transcriptional activation of the genes encoding these enzymes (4) . The P450 4A enzymes characteristically catalyze the W-hydroxylation of fatty acids, which can be further oxidized to dicarboxylic acids.
1To whom correspondence and reprint requests should be addressed, COUP TF-1, chicken ovalbumin upstream transcription factor 1; CTE, carboxy-teiminal extension; HNF-4, hepatocyte nuclear factor 4; RXRa, retinoid X receptor alpha; PPAR, peroxisome proliferstor-activated receptor PPAR-C, a mutant form of PPARz; PPRE, peroxisome proliferator response element; P450, a generic term for a cytochrome P.450 monooxygenase, individual P450s are designated according to a uniform system of nomenclature (5) and the gene designations are preceded by the letters CYP; Wy-14.643: pirinixic acid ([4-chloro-6(2,3-xylindino)2-pyrimidinylthiolacetic acid).
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The FASEBJournal JOHNSON ETAL heart, and adrenal (20) . Similar distributions of mRNA and protein are also evident in mouse tissues, where the elevated expression of PPARct in intrascapular brown adipose tissue was also noted (22) . P450 4A enzymes are also found in abundance in the liver and kidney (23) . A third mammalian PPAR, NUC-1 (24) , which is most closely related to the X. laevi.s PPAR3, has been designated either as PPAR or as PPAR6 (20) . Rat (20, 24) and mouse (22) PPAR mRNAs are also distributed widely, showing the highest abundance in the heart, adrenals, spleen, and intestine. PPAR8 mRNAs are expressed throughout the embryonic period in mice, whereas the PPARU and PPART mRNAs were detected only during late gestation (20, 25) .
The mammalian PPARs also exhibit differential activation by various agonists. The peroxisome proliferator Wy-14,643 is one of the most potent activators reported to date for PPARa (7) . However, PPAR6 is more responsive to fatty acids than to Wy-14,643 (20, 24 In the case of arachidonic acid, the rn-hydroxyarachidonic acid formed by the actions of P450 4A enzymes has been implicated in the regulation of renal vascular tone (34) . Although other mammalian P450 enzymes also oxidize fatty acids, they generally do not exhibit the high degree of specificity exhibited by the P450 4A enzymes for the terminal, primary C-H bonds of the fatty acid in preference to adjacent and more easily ondized secondary C-H bonds at the rn-i and tL-2 carbons.
As reviewed recently by O'Kita (35), the significance of tl-hydroxylation as a pathway for the metabolism of saturated fatty acids is poorly understood, although it is likely to contribute to the formation of dicarboxylic acids through the subsequent oxidation of the product rn-alcohols by cytosolic enzymes. Dicarboxylic fatty acids are substrates for mitochondrial or peroxisomal 13-oxidation, and the peroxisomal pathway appears to he more efficient for the [3-oxidation of dicarboxylic acids than the mito- (1, 35) . This difference suggests that microsomal rn-hydroxylation would shunt fatty acids to peroxisomes for degradation, which in turn would affect energy conservation from fatty acid oxidation, as the initial step of the peroxisomal pathway is not coupled to ATP production, as it is in the mitochondrial pathway (1). In some cases, [3-oxidation may be incomplete leading to the production of dicarboxylic fatty acids of intermediate length, C6-C10. The tissue, plasma, and urinary levels of C6-C10 dicarboxylic acids are generally elevated during fasting and diabetic states where the concentrations of circulating fatty acids are increased by lipolysis in adipocytes (36) . Under these conditions, the hepatic concentrations of P450 4A enzymes are also elevated (37) (38) (39) 
PPARa ACTIVATES TRANSCRIPTION OF THE CYP4A6 GENE
Among the rabbit P450 4A enzymes, the induction of P450 4A6 is greatest by the peroxisome proliferators (31) , and the characterization of response elements in this gene has been the focus of work in our laboratory. As illustrated in Fig. 1 PPAR6 exhibits very weak responses with these agonists.
PPARa elicits significant transcriptional activation of the CYP4A6 reporter in the absence of added peroxisome proliferators, and this effect will be referred to as intrinsic transactivation (Fig. 1) . This intrinsic transactivation exceeded 50% of the maximum activation achieved in the presence of Wy-14,643 in several cell lines (42) . However, the level of intrinsic transactivation is much lower when an expression vector for a mutant receptor, PPAR-G, was used in these experiments (Fig. 1 , Alpha-C). PPAR-G was obtained as an artifact of the cloning of the cDNA for PPARa by PCR, and has a substitution of glycine for glutamic acid 282 located in the beginning of the putative ligand binding domain of PPARa (15) . The phenotypic difference in intrinsic transactivation seen between the wild-type PPARa and PPAR-G remained when the serum used in the medium was treated with activated charcoal in order to remove potential agonists (42 (triangles), or pLuc-TK-ACO (circles) into HepC2 cells as described (42) . The data are expressed relative to the normalized luciferase activity obtained from cells transfected with PPARa-G and treated with 50 ILM Wy-14,643. This value was arbitrarily set to 100. The final concentration of 643 added to the medium is indicated on the X axis. Nonlinear regression was used to generate the curves shown and to estimate the EC50 values using one-site ligand binding equations. GAGAGCAAGGTAGAAGGTCAAGA  CAAATGTAGGTAATAGTTCAATA  CAAATATAGGCCA  TAGGTCAGTG  TCTACCA000TAAAGGT  TOAAGO  AAAAACTGGGCCAAAGGTCTCAO  GCATTCTOGOTCAAAGTTGATCC  CACAACTGGGATAAAGGTCTCGC  ACTCCCA  CGGCCA  AAGGTCA  TGA  TCTCTCT000TGAAATGTGCATT  T CT TACIGGAT  CAGAGITCA  CIA  01 CII  TCA000CA  TCAGTCA  CAT  TCTCTCC000TAAAOGTGAA  GGC  GGCAACGGGGTAA  AGGT  TCAGGT CYP4A GENE REGULA11ON 1245 ment indicates that the extended binding site exhibits a consensus sequence 5' of the DR1 motif (Fig. 3) . (Fig. 3) . This suggests that these monomeric receptors may also regu- This region is similar to the binding site for the monomeric nuclear receptors Rev-ErbA (59) and ROR/RZR (60) . A chimera between the zinc finger domain of RXRa and the CTE of PPARa also binds as a monomer, indicating that the CTE of PPARa contributes to the recognition of the 5' extended region (unpublished).
The requirement of the 5' extended site for binding of PPARx/RXRa heterodimers but not for RXRa homodimers indicates that PPARa interacts with the extended site and the 5' core binding site. This polarity is opposite to that seen for the heterodimer of RXRa with the thyroid hormone receptor when bound to a DR4 motif (65 and HNF-4 also bound well to both DRiP and DR1M (Fig. 4) . However, complex formation by these homodimers with the Z element was less than 10% of that observed with the DRiP oligonucleotide, indicating that they hound poorly to the imperfect core binding sites in the DR1 motif of the natural PPRE. In contrast, the association of PPARcx/RXRcz with the Z element with its imperfect core binding sites was similar to that seen for DRiP, indicating a compensatory role for the 5' extended site.
Other natural PPREs, such as those found in the genes for the bifunctional enzyme and HMG-CoA synthase, exhibited a similar pattern of relative complex formation (Fig. 4) , suggesting that they share common determinants promoting specificityfor PPARx/RXRa binding. Each of these PPREs exhibit conserved 5' extended binding sites and poor conservation of each of the core binding sites that form the DR1 motif. We suspect that the poor association of RXRx, ARP-1, and HNF-4 homodimers with these PPREs reflects the poor conservation of both core binding sites in the DR1 motif as well as the absence of compensatory interactions by these other receptors with the 5' extended binding site used by PPARcxJRXRa.
The binding of homodimers of ARP-1 and HNF-4 was greater when the 3' core binding site of the DRJ motif conformed to the consensus, such as the PPREs from the peroxisomal ACO and the liver fatty acid binding protein (Fig. 4) 
